From Regulatory Roadblock to Independent CQC-Registered Medical Cannabis Provider

Releaf is a specialist UK medical cannabis healthcare provider offering patients access to consultations, personalised treatment plans and cannabis-based medicines through a predominantly digital healthcare model.

The Releaf proposition was built around making access to medical cannabis more streamlined, combining specialist clinical consultations with technology, patient support and an integrated treatment journey.

Today, Releaf has developed into a substantial specialist healthcare platform, with more than 240,000 people within its community and a multidisciplinary network of specialist doctors supporting patients across a range of clinical conditions.

However, establishing the business in the UK presented an immediate regulatory challenge.

Releaf's proposed model involved the assessment and treatment of patients by healthcare professionals and therefore required careful consideration of the Care Quality Commission regulatory framework.

At the point Releaf approached QMADS, the organisation did not yet have the independent regulatory infrastructure required for its intended operating model.

The business had already invested significant capital into entering the UK market, but its ability to commence and scale the relevant healthcare services independently was constrained while its CQC position remained unresolved.

This meant that the registration issue was no longer simply a compliance exercise.

It had become a commercially critical market-entry issue.

Medical cannabis sits within one of the more complex areas of private healthcare regulation.

Although cannabis-based products for medicinal use are prescribed within a specialist clinical framework, a medical cannabis clinic is not simply an online platform or medication supply business.

The underlying patient journey can involve:

• clinical assessment;
• review of medical history and previous treatment;
• consultations with specialist doctors;
• clinical decision-making;
• diagnosis and assessment of existing conditions;
• creation and review of treatment plans;
• prescribing;
• ongoing monitoring;
• multidisciplinary clinical oversight; and
• treatment of disease, disorder or injury.

Where a provider is responsible for carrying on regulated healthcare activities in England, the appropriate legal entity must be registered with CQC unless an applicable exemption exists.

For Releaf, the challenge therefore extended beyond completing an application form.

A viable regulatory structure had to be established around an emerging healthcare business that was simultaneously attempting to enter the market, develop its infrastructure and control ongoing capital expenditure.

At the point of engagement, several fundamental components of the regulatory pathway required development, including:

• the CQC registration application;
• regulatory positioning of the service model;
• the provider's policy and governance framework;
• supporting registration evidence;
• financial viability considerations;
• Registered Manager and leadership readiness;
• preparation for the CQC registration interview; and
• a workable route for the organisation while its own registration remained in progress.

The commercial consequences of delay were significant.

Releaf was investing in its platform, clinical proposition and market entry while regulatory approval remained a dependency to independent service delivery.

The challenge therefore became:

How could the business continue progressing commercially while simultaneously building the regulatory infrastructure required to operate independently?

QMADS was engaged to provide a broader regulatory solution rather than simply completing a CQC application.

Our work addressed both sides of the problem:

Immediate Market-Entry Requirement

and

Long-Term Independent CQC Registration

The objective was to create a structured pathway through which Releaf could progress from regulatory dependency to operating independently under its own CQC registration.

The engagement involved four principal workstreams.

Establishing a Transitional Operating Arrangement

One of the most commercially significant aspects of the engagement was addressing the period between Releaf entering the UK market and obtaining its own CQC registration.

QMADS facilitated a transitional arrangement involving an existing CQC-registered healthcare provider within our client network.

The purpose was to establish an interim framework through which the relevant healthcare service could operate while Releaf's own CQC application progressed.

Any such structure requires a clear distinction between the commercial brand and the legal entity responsible for carrying on the regulated activity.

The registered provider must retain the appropriate regulatory responsibility, governance and oversight for the regulated activities carried on within its registration.

This provided Releaf with an important transitional route while the organisation continued developing the regulatory infrastructure required to become independently registered.

It also addressed a significant commercial problem: reducing the period during which the organisation's UK market-entry investment was unable to translate into operational service delivery.

CQC Registration

Alongside the transitional operating model, QMADS progressed Releaf's application for its own CQC registration.

The registration work required the proposed service to be translated into an appropriate regulatory framework.

This included consideration of:

Legal Entity → Service Model → Regulated Activity → Clinical Governance → Registered Manager → Location → CQC Application

For specialist services such as medical cannabis, the application must accurately reflect how clinical responsibility, prescribing, patient assessment, treatment and governance operate in practice.

QMADS supported Releaf through the preparation and progression of this registration pathway.

The ultimate objective was clear:

Releaf needed to move from operating within another registered provider's regulatory framework to holding its own CQC registration and assuming independent regulatory responsibility for its service.

Policies and Governance Infrastructure

CQC registration requires considerably more than an application form.

Providers must be capable of demonstrating how their proposed service will operate safely, effectively and in accordance with the applicable regulations.

Releaf therefore required an appropriate policy and governance framework around its service.

QMADS supported the development of the policies and supporting regulatory infrastructure required for the proposed operating model.

For a specialist prescribing service, this extends across areas such as:

• clinical governance;
• medicines management;
• safeguarding;
• consent;
• patient safety;
• risk management;
• complaints;
• incident management;
• information governance;
• recruitment and workforce governance;
• duty of candour;
• quality assurance; and
• management oversight.

The purpose was not simply to produce a collection of documents.

The policy framework needed to demonstrate how the organisation intended to govern a specialist clinical service once independently registered.

Registration Interview Preparation

Obtaining CQC registration also requires the individuals responsible for the service to demonstrate that they understand the service they propose to operate and their regulatory responsibilities.

QMADS therefore provided CQC interview preparation as part of the registration programme.

This focused on helping leadership prepare for questioning around areas including:

• the proposed service model;
• patient safety;
• governance;
• safeguarding;
• medicines management;
• clinical risk;
• staffing and competency;
• regulatory responsibilities;
• quality monitoring; and
• the role and responsibilities of the Registered Manager.

The objective was not to provide scripted answers.

It was to ensure that the individuals responsible for the service could articulate how the organisation would operate and demonstrate their understanding of the regulatory framework within which they would be working.

The most important aspect of the Releaf engagement was the transition.

The interim operating arrangement was never intended to replace Releaf obtaining its own CQC registration.

It served as a transitional mechanism while the organisation established the infrastructure necessary to operate independently.

Once Releaf achieved the appropriate CQC registration, QMADS assisted with the transition away from the interim provider arrangement.

This allowed Releaf to move from:

Interim Registered Provider Framework

→ Releaf CQC Application

→ Policies & Governance Infrastructure

→ CQC Registration Assessment

→ Registration Achieved

→ Transition from Interim Arrangement

→ Independent Service Delivery

This represented the completion of the regulatory market-entry strategy.

Releaf could now operate the relevant regulated service through its own registered provider structure rather than remaining dependent upon another organisation's registration framework.

Releaf successfully progressed to its own CQC registration.

CQC's current register records Releaf Dispensary Clinics Ltd, also known as Releaf Clinics, as a registered provider carrying on the regulated activity:

Treatment of Disease, Disorder or Injury

The organisation now operates as a CQC-regulated private medical cannabis clinic.

The business has subsequently developed considerably.

Releaf currently reports a community exceeding 240,000 people and a clinical network of more than 55 specialist doctors, delivering a technology-enabled patient pathway covering eligibility, specialist consultation, treatment planning, prescribing and ongoing clinical support.

For QMADS, however, the most important outcome of the engagement was not Releaf's subsequent commercial growth.

It was the regulatory transition achieved during the engagement:

From a business constrained by the absence of its own registration to an independently CQC-registered healthcare provider.

The commercial growth that followed belongs to Releaf.

QMADS' contribution was helping establish and navigate the regulatory pathway that enabled the organisation to reach independent regulatory status.

The Releaf case demonstrates that CQC registration can become much more than an administrative requirement.

For a new entrant investing heavily in the UK healthcare market, delays or weaknesses within the regulatory strategy can directly affect:

• launch timescales;
• capital expenditure;
• revenue commencement;
• investor expectations;
• clinical recruitment;
• commercial partnerships;
• patient acquisition;
• operational planning; and
• the overall viability of the market-entry strategy.

The situation becomes particularly complex where a provider:

• is entering the UK healthcare market for the first time;
• has already committed significant investment;
• needs CQC registration before operating independently;
• provides specialist or emerging treatments;
• relies on remote or technology-enabled healthcare delivery;
• requires a comprehensive clinical governance infrastructure;
• needs an interim operating solution;
• is building the business while registration is progressing; or
• ultimately needs to transition from another provider's regulatory framework to its own registration.

These businesses require more than application preparation.

They require a regulatory market-entry strategy.

The Releaf engagement demonstrates QMADS' ability to look beyond the CQC application itself and address the wider operational and commercial consequences of registration.

It involved supporting an organisation through three distinct phases:

ENTER → REGISTER → TRANSITION

Enter the market within an appropriate regulatory structure.

Build and secure independent CQC registration.

Transition the service into its own regulated operating framework.

That is fundamentally different from simply completing a CQC form.

Healthcare entrepreneurs, investors and established international providers can develop excellent commercial propositions but still encounter significant difficulties when translating those models into the UK regulatory environment.

QMADS provides specialist support covering:

CQC Registration | Regulatory Scope & Market-Entry Strategy | Medical Cannabis Services | Policies & Clinical Governance | Financial Viability & Registration Evidence | Registered Manager Preparation | CQC Interview Preparation | Transitional Regulatory Planning | Compliance & Regulatory Consultancy

Our role is not limited to preparing documentation.

Where a business model presents a complex regulatory problem, we work with the provider to establish a practical pathway from concept and market entry through to regulatory independence.